Location: Boston MA, Chapel Hill NC, Chicago IL, St Louis MO,
Sponsor: CRISPR Therapeutics
Sex: All
Age: 18 - 70
Code: NCT06925542
Phase1, Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
for
Lupus Nephritis
Location: Queens NY, Hackensack NJ, Montreal, Toronto, Atlanta GA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 5 - 17
Code: NCT05039619
Phase2, Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
for
Lupus Nephritis, Primary Membranous Nephropathy
Location: Worcester MA, New York NY, Syracuse NY, Plantation FL,
Sponsor: Nkarta, Inc.
Sex: All
Age: 18 - 70
Code: NCT06557265
Phase1, Phase2, Recruiting
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
for
Lupus Nephritis
Location: Baltimore MD, Charlotte NC, Columbus OH, Hixson TN